Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Return on Invested Capital: 2022-2024

Historic Return on Invested Capital for Centessa Pharmaceuticals (CNTA) over the last 1 years, with Jun 2024 value amounting to -0.62%.

  • Centessa Pharmaceuticals' Return on Invested Capital fell 4.00% to -0.62% in Q2 2024 from the same period last year, while for Jun 2024 it was -0.62%, marking a year-over-year decrease of 4.00%. This contributed to the annual value of -0.51% for FY2023, which is N/A change from last year.
  • Centessa Pharmaceuticals' Return on Invested Capital amounted to -0.62% in Q2 2024, which was down 3.93% from -0.59% recorded in Q1 2024.
  • In the past 5 years, Centessa Pharmaceuticals' Return on Invested Capital registered a high of -0.57% during Q3 2023, and its lowest value of -0.66% during Q1 2023.
  • Moreover, its 3-year median value for Return on Invested Capital was -0.59% (2024), whereas its average is -0.60%.
  • Data for Centessa Pharmaceuticals' Return on Invested Capital shows a peak YoY increase of 7bps (in 2024) and a maximum YoY decrease of 4bps (in 2024) over the last 5 years.
  • Over the past 3 years, Centessa Pharmaceuticals' Return on Invested Capital (Quarterly) stood at -0.60% in 2022, then remained steady at -0.59% in 2023, then dropped by 4bps to -0.62% in 2024.
  • Its Return on Invested Capital stands at -0.62% for Q2 2024, versus -0.59% for Q1 2024 and -0.59% for Q4 2023.